Today news
About the same in other media
GSK/Sanofi Covid booster delayed by lack of uninfected people to test it on
Reading now: 659
theguardian.comEfforts by the British and French drugmakers GSK and Sanofi Pasteur to produce a Covid-19 vaccine have suffered a further setback, with final clinical data on the jab and a potential launch delayed until next year as they struggle to find enough uninfected people to test it on.
The two vaccine specialists announced positive preliminary results from a trial that showed the vaccine raised antibody levels against Covid by nine to 43 times when given as a single booster shot in people who had already received doses of AstraZeneca, Johnson & Johnson, Moderna or Pfizer/BioNTech vaccines, for all age groups.
There were no safety concerns, according to an independent review body. It is the most comprehensive booster trial to date, said GSK and
Read more on theguardian.comAbout this in other media
Cruise ships denied docking over COVID cases as more flights cancelled euronews.com /2 years ago
COVID-19: Austrian resorts concerned over new tourist entry rules euronews.com /2 years ago
Government plans UK-wide Covid booster alert to mobile phones theguardian.com /2 years ago
Show more
The website finance-news.co is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
